Breed's Hill Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$539K Sell
3,526
-4
-0.1% -$615 0.26% 60
2025
Q1
$585K Buy
3,530
+150
+4% +$23.5K 0.32% 49
2024
Q4
$489K Buy
3,380
+409
+14% +$63.4K 0.26% 68
2024
Q3
$481K Buy
2,971
+163
+6% +$26K 0.39% 43
2024
Q2
$410K Sell
2,808
-103
-4% -$15.3K 0.36% 46
2024
Q1
$460K Sell
2,911
-161
-5% -$25.6K 0.42% 42
2023
Q4
$482K Buy
+3,072
New +$471K 0.47% 36

Other funds holding JNJ

Breed's Hill Capital's JNJ Position: Q2 2025 in Review

Breed's Hill Capital reduced its Johnson & Johnson (JNJ) stake by 0.11% in Q2 2025, selling an estimated $615 and leaving 3,526 shares worth $539K. The position accounts for 0.26% of the portfolio, ranked #60.

Breed's Hill Capital first reported a position in JNJ in Q4 2023 and has held it in 7 quarters since. The position peaked at $585K in Q1 2025. 4,090 funds tracked by Wall St. Rank hold JNJ as of Q2 2025.

  • Breed's Hill Capital held 3,526 shares of Johnson & Johnson worth $539K as of Q2 2025.
  • Breed's Hill Capital sold 4 Johnson & Johnson shares in Q2 2025, an estimated $615.
  • Johnson & Johnson made up 0.26% of Breed's Hill Capital's portfolio in Q2 2025, its #60 holding.
  • Breed's Hill Capital first reported a position in Johnson & Johnson in Q4 2023 and has held it in 7 quarters since.
  • Breed's Hill Capital's Johnson & Johnson position peaked at $585K in Q1 2025.
  • 4,090 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2025.

Based on Breed's Hill Capital's 13F filing for Q2 2025, filed 8 Aug 2025.